Corrigendum: Empagliflozin alleviates hepatic steatosis by activating the AMPK-TET2-autophagy pathway in vivo and in vitro
Saved in:
Main Authors: | Ting Li, Ting Fang, Linxin Xu, Xiangyang Liu, Xiaoyu Li, Mei Xue, Xiaochen Yu, Bei Sun, Liming Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1478437/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro
by: Ting Li, et al.
Published: (2021-01-01) -
Responses of endogenous proline in rice seedlings under chromium exposure
by: X.Z. Yu, et al.
Published: (2016-12-01) -
Short-term effects of empagliflozin on preventing contrast induced acute kidney injury in patients undergoing percutaneous coronary intervention, a randomised trial
by: Zeinab Sadat Hosseini, et al.
Published: (2025-01-01) -
Metformin ameliorates peripheral neuropathy in diabetic rats by downregulating autophagy via the AMPK pathway
by: Fangqin You, et al.
Published: (2025-01-01) -
Adjuvant Treatment with Empagliflozin or Semaglutide Increases Endothelial Progenitor Cells in Subjects with Well-Controlled Type 1 Diabetes Mellitus
by: Maja Preložnik Navodnik, et al.
Published: (2025-01-01)